Clinical Trials for Anchen

Explore 20 clinical trials worldwide

Showing 1-20 of 20 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Anchen

Clinical Trials (20)

NCT07155265
REMIMID-ICU: Remimazolam vs Midazolam for Deep Sedation in Hemodynamically Unstable, Mechanically Ventilated Adults
PHASE3Not yet recruiting
180 participants
Started: Oct 1, 2025 · Completed: Sep 30, 2027
1 condition1 sponsor0 locations
NCT07153744
Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction
PHASE4Not yet recruiting
9,588 participants
Started: Sep 1, 2025 · Completed: Dec 31, 2029
2 conditions106 sponsors1 location
NCT06841822
The Impact of Ultrasound-Guided Superficial and Deep Paravertebral Nerve Blocks at the Superior Costotransverse Ligament on Hemodynamics During the Induction Phase of Thoracoscopic Lung Lobectomy: A Multicenter, Double-Blind, Randomized Controlled Trial
NARecruiting
168 participants
Started: May 25, 2025 · Completed: Jun 30, 2026
3 conditions5 sponsors1 location
NCT06760065
Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment
PHASE3Not yet recruiting
316 participants
Started: Jan 15, 2025 · Completed: Dec 31, 2027
1 condition7 sponsors0 locations
NCT06898723
The Preventive Effect of Shenfu Injection on Myocardial Dysfunction in Sepsis
PHASE4Recruiting
440 participants
Started: Oct 1, 2024 · Completed: Sep 30, 2026
2 conditions18 sponsors1 location
NCT04974138
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
PHASE4Recruiting
32,000 participants
Started: Aug 22, 2024 · Completed: Jun 30, 2030
4 conditions22 sponsors20 locations
NCT04974151
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
PHASE4Recruiting
24,000 participants
Started: Aug 22, 2024 · Completed: Jun 30, 2029
2 conditions22 sponsors20 locations
NCT06538883
Sedation in ICU Patients With Mechanical Ventilation
NANot yet recruiting
366 participants
Started: Aug 1, 2024 · Completed: Jul 30, 2026
2 conditions32 sponsors0 locations
NCT06429865
Cytosponge in Surveillance After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma
NAEnrolling by invitation
1,000 participants
Started: May 31, 2024 · Completed: Dec 31, 2024
1 condition10 sponsors1 location
NCT06243666
Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
N/AActive, not recruiting
2,188 participants
Started: Feb 20, 2024 · Completed: Dec 31, 2026
3 conditions3 sponsors1 location
NCT06254690
The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical Study
PHASE2Recruiting
102 participants
Started: Jan 1, 2024 · Completed: Dec 1, 2026
1 condition12 sponsors1 location
NCT06232694
Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML
NARecruiting
54 participants
Started: Jan 1, 2024 · Completed: Dec 30, 2027
1 condition3 sponsors1 location
NCT06162780
TEER for Severe DMR of Low to Intermediate Surgery Risk
N/ARecruiting
160 participants
Started: Jan 1, 2024 · Completed: Dec 31, 2026
1 condition29 sponsors1 location
NCT05909293
Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission
NARecruiting
100 participants
Started: Apr 12, 2023 · Completed: May 30, 2028
1 condition3 sponsors1 location
NCT06515964
China Early Esophageal Cancer Cohort
N/ARecruiting
1,000 participants
Started: Oct 1, 2022 · Completed: Oct 1, 2025
1 condition21 sponsors1 location
NCT05657639
CAV Regimen for R/R AML
PHASE2Recruiting
68 participants
Started: Oct 1, 2022 · Completed: Oct 1, 2025
1 condition12 sponsors1 location
NCT05343377
A Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma
NANot yet recruiting
72 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2028
1 condition9 sponsors1 location
NCT05179733
The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years
PHASE3Recruiting
280 participants
Started: Mar 2, 2022 · Completed: Dec 25, 2025
1 condition29 sponsors1 location
NCT05522582
Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors
PHASE2Active, not recruiting
50 participants
Started: Nov 15, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04440670
Effect of Autologous Cord Blood Mononuclear Cells for Prevention of Bronchopulmonary Dysplasia or Death in Extremely Preterm Neonates
PHASE3Recruiting
140 participants
Started: Jun 20, 2020 · Completed: Dec 31, 2023
1 condition14 sponsors2 locations